Ablation
Annexin V/PI
Antibiotic prophylaxis
biochemical recurrence
Bladder
bladder xanthoma
Cancer
case report
caspase 3/7
cystoscopy
FBLN2 (fibulin 2)
Gastric cancer
gavage injector
high-grade
high-risk bladder cancer
HTB-9 (5637)
hyperlipidemia
ISUP grade group
lipid
Local recurrence
lymphocyte-to-monocyte ratio
melatonin
metastases
metastasis
Mp-MRI
MSI (microsatellite instability)
negative surgical margins
neuropeptide-Y
neutrophil-lymphocyte ratio
Non-muscle invasive bladder cancer
NPY
oligometastatic
paraganglioma
perineural invasion
platelet-to-lymphocyte ratio
positive surgical margins
povidone-iodine
prediction of recurrence
progression
prostate biopsy
prostate MRI
prostate needle biopsy
prostate spesific antigen
PSA
PSA density
PSAD
pT1-2
radical cystectomy
radical nephrectomy
radiofrequency ablation
radiotherapy
RCC
rectal suppository
recurrence-free survival
renal cell carcinoma
renal tumor
RT-112
seconder prostate neoplasm
STARD3
survival
transurethral resection of bladder
trimodal therapy
tumor
tumor percentage
upgrade
Urine cytology
variant histopathology
Xanthoma
